Chennai, Nov 29 (IANS) Biocon (NS:BION) Biologics Ltd, a subsidiary of listed biopharmaceutical company Biocon Ltd, on Tuesday announced the completion of its acquisition of global...
- Day's Range
- 281.85 - 283.50
- 52 wk Range
- 258.25 - 410.70
- Prev. Close
- Average Vol.(3m)
- 1-Year Change
- Market Cap
- P/E Ratio
- Shares Outstanding
- Dividend (Yield)
- 0.5 (0.18%)
- Next Earnings Date
- Jan 21, 2023
New Delhi, Nov 24 (IANS) MakeMyTrip's B2B platform MyBiz has doubled its bookings over last year and grown more than three times over pre-Covid period, the company said on Thursday. MyBiz...
By Malvika Gurung Investing.com -- Apollo Tyres (NS:APLO): The tyre manufacturer’s consolidated profit rose 12% YoY to Rs 194.5 crore in Q2, thanks to on-time pricing actions and cost...
By Malvika Gurung Investing.com -- The domestic market opened the new week on a flat note, following mixed global cues as Asian shares eased in early trade on Monday, following a top Fed...
I am devastated, will always be guided by John, says Biocon chief Kiran Majumdar-Shaw on demise of husband
Bengaluru, Oct 25 (IANS) Biocon (NS:BION) Chief Kiran Majumdar-Shaw, who lost her husband, stated that she is devastated. Sharing her thoughts on social media on Tuesday, she maintained...
Bengaluru, Oct 24 (IANS) Biocon (NS:BION) founder Kiran Mazumdar-Shaw's husband and former vice-chairman of the firm, John Shaw died here on Monday. According to sources, John Shaw, 70,...
Bengaluru, Aug 4 (IANS) The Securities Appellate Tribunal (SAT) in a recent ruling quashed the charges of insider trading in Biocon (NS:BION) levelled against Shreehas P. Tambe, President...
By Malvika Gurung Investing.com -- A slew of companies is lined up to conduct different corporate actions on Friday, including June quarterly earnings announcements and board meetings, among...
By Malvika Gurung Investing.com -- Tata Consultancy Services (NS:TCS): The IT heavyweight has inked a multi-year, multi-million dollar deal with Marks & Spencer, as it has been working...
Bengaluru, July 27 (IANS) Global biopharmaceuticals company Biocon (NS:BION) on Wednesday reported 23 per cent rise in revenue for the first quarter of financial year 2023, at Rs 2,217...
By Malvika Gurung Investing.com -- ONGC (NS:ONGC): The Maharatna company signed an MoU with the leading renewable energy company Greenko Group to jointly come up with opportunities in...
By Malvika Gurung Investing.com -- The country’s most valued company by market capitalization Reliance Industries (NS:RELI) posted a double-digit bottomline growth, along with the best...
By Malvika Gurung Investing.com -- Tata Consultancy Services (NS:TCS): The IT giant will transform the IT structure of the Finnish stainless steel maker Outokumpu and will develop a...
By Malvika Gurung Investing.com -- Infosys (NS:INFY)s: The IT giant has agreed with the US-based early stage venture capital fund The House Fund III for an investment amount of $10...
By Malvika Gurung Investing.com -- Biocon: Subsidiary Biocon (NS:BION) Biologics has denied any allegations of bribery against its company and officials with the approval process of one of...
New Delhi, June 21 (IANS) The Central Bureau of Investigation (CBI (NS:CBI)) has said that they have apprehended a Joint Drug Controller (JDC) of Central Drugs Standard Control Organisation...
By Malvika Gurung Investing.com -- Shares of the biopharmaceutical company Biocon (NS:BION) surged on Thursday, after BofA Securities held its buy rating on the stock, and sees a potential...
Bengaluru, June 7 (IANS) The debate on poor infrastructure, especially the dismal condition of roads in Bengaluru city, which is known as the Silicon Valley of India, has come to the fore...
By Malvika Gurung Investing.com -- Hindustan Petroleum Corporation(NS:HPCL): The oil company’s net profit dropped 40% YoY to Rs 1,795.26 crore in the March quarter, higher than the...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.